| Product NDC: | 0603-3741 |
| Proprietary Name: | Furosemide |
| Non Proprietary Name: | furosemide |
| Active Ingredient(s): | 80 mg/1 & nbsp; furosemide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0603-3741 |
| Labeler Name: | Qualitest Pharmaceuticals |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076796 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20040326 |
| Package NDC: | 0603-3741-04 |
| Package Description: | 180 TABLET in 1 BOTTLE, PLASTIC (0603-3741-04) |
| NDC Code | 0603-3741-04 |
| Proprietary Name | Furosemide |
| Package Description | 180 TABLET in 1 BOTTLE, PLASTIC (0603-3741-04) |
| Product NDC | 0603-3741 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | furosemide |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20040326 |
| Marketing Category Name | ANDA |
| Labeler Name | Qualitest Pharmaceuticals |
| Substance Name | FUROSEMIDE |
| Strength Number | 80 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Increased Diuresis at Loop of Henle [PE],Loop Diuretic [EPC] |